Decoding the role of RPL38 in lung adenocarcinoma: a multi-omics approach
RPL38 plays a tumor‑promoting role in LUAD. This study clarifies the contribution of RPL38 to LUAD development, provides new insights into its pathogenesis, and suggests a rationale for therapeutic targeting of RPL38 in LUAD treatment.
Authors
- Qiuxia Liu Liu
- Fengsheng Dai (ORCID: https://orcid.org/0000-0002-4202-9173)
- Zhiqiang Wang (ORCID: https://orcid.org/0000-0002-0801-4859)
- Liang Zhang (ORCID: https://orcid.org/0000-0002-2694-1779)
- Chenguo Yao
- Fei Teng
- Liang Yu
- Yuan Wang
- Yang Chen
Institutions
- Chongqing University (CN)
- New Technology (Israel) (IL)
- Chongqing Cancer Hospital (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2026-02-12
- DOI
- https://doi.org/10.3389/fimmu.2026.1778481
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00